Related Experiment Video
Updated: Aug 3, 2026
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Published on: March 8, 2012
A Rare Case of Dual Clonal B-Cell Hairy Cell Leukemia: Diagnostic Challenges
Insights
Hairy Cell Leukemia (HCL) is a rare B-cell cancer. Early diagnosis using flow cytometry and genetic testing, followed by cladribine chemotherapy, proved effective in treating a patient with dual clonal B-cell populations.
Area of Science:
- Hematology
- Oncology
Background:
- Hairy Cell Leukemia (HCL) is a rare chronic B-cell malignancy.
- Characterized by cytopenia, splenomegaly, and bone marrow infiltration.
- A case of HCL presenting with gingival bleeding and multi-organ involvement is described.
Background:
Hairy Cell Leukemia (HCL) is a rare chronic B-cell disorder characterized by cytopenia, splenomegaly, and bone marrow infiltration. A 42-year-old female presented with gingival swelling and bleeding, later diagnosed with HCL involving lymph nodes, liver, and spleen.
Methods:
The patient underwent blood tests, PET-CT, bone marrow flow cytometry, biopsy, and lymph node as-piration, confirming HCL. Notably, flow cytometry revealed dual clonal B-cell populations, both CD5-negative and CD10-negative. Immunohistochemistry showed positive B-cell markers (CD20, CD23) and BRAF-V600E mu-tation. Cladribine chemotherapy began on April 18, 2022, followed by supportive treatment.
Results:
Blood tests showed pancytopenia, and PET-CT indicated lymph node, spleen, liver, and bone marrow involvement. Bone marrow biopsy confirmed HCL with fibrosis. The patient experienced bone marrow suppression during chemotherapy and received supportive care, eventually leading to a successful discharge.
Conclusions:
HCL is a rare B-cell malignancy causing pancytopenia and organ involvement. The identification of dual clonal B-cell populations is crucial for accurate diagnosis. Early diagnosis and cladribine chemotherapy are effective. Immunohistochemical and genetic testing are key for diagnosis and treatment planning.
More Related Videos
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
